Seshu Tyagarajan Candel Therapeutics, Inc. (CADL) insider trading activity

Seshu Tyagarajan is Chief Technology Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 125,657 shares of CADL, which is worth approximately $1.1 Million. The most recent transaction as insider was on Nov 29, 2024, when has been sold 20,392 shares (Common Stock) at a price of $4.56 per share, resulting in proceeds of $92,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K

13.96% 3M change

27.88% 12M change

Total Value Held $1.1 Million

Seshu Tyagarajan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 29 2024	SELL Open market or private sale	$92,987 $4.56 p/Share	20,392 Reduced 13.96%	125,657 Common Stock
Jul 17 2024	SELL Open market or private sale	$96,085 $6.47 p/Share	14,851 Reduced 9.23%	146,049 Common Stock
Jul 11 2024	SELL Open market or private sale	$79,580 $5.97 p/Share	13,330 Reduced 7.65%	160,900 Common Stock
Nov 28 2023	SELL Payment of exercise price or tax liability	$15,595 $0.9 p/Share	17,328 Reduced 9.05%	174,230 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	104,516 Added 35.3%	191,558 Common Stock
Dec 09 2022	BUY Open market or private purchase	$19,990 $1.93 p/Share	10,358 Added 43.68%	13,358 Common Stock
Dec 08 2022	BUY Open market or private purchase	$5,070 $1.69 p/Share	3,000 Added 50.0%	3,000 Common Stock
Nov 28 2022	BUY Grant, award, or other acquisition	-	73,684 Added 50.0%	73,684 Common Stock

Seshu Tyagarajan

Chief Technology Officer

Needham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Value

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Candel Therapeutics, Inc.

Track Activities on CADL

Account